Pediatric Dermatology · 2004 · 59 citations · 14 references
MedicineInfectious DiseasesPediatricsMycologyPediatric DermatologyPediatric Infectious DiseasesAntifungal AgentsAntifungal PharmacotherapyAntifungal TherapyDrug-induced PhotosensitivityFungal InfectionsFungal PathogenesisAspergillosis TherapyChronic Granulomatous DiseaseInvasive Aspergillosis TreatmentNew Antifungal AgentsPediatric Antifungal TherapyPhotodamagePhotodamage TreatmentPhotosensitizing Antifungals
Voriconazole is a new triazole antifungal agent with activity against a wide range of systemic fungal pathogens, including Aspergillus spp. Photosensitivity is a rarely reported side effect of voriconazole, hypothesized to be a result of retinoid-like effects. We report two children with chronic granulomatous disease to whom voriconazole was administered for chronic invasive aspergillosis. Severe photosensitivity occurred in both patients, one of whom had striking photodamage at the 5-month follow-up.
14
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Jerry A. Winkelstein, Mary C. Marino, Richard B. Johnston et al. · Medicine · 2000 · 1.7K citations